UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 285

Sortiert nach

Dialysis water and fluid purity: more than endotoxin

Nephrology, dialysis, transplantation, 2012-11, Vol.27 (11), p.4010-4021

2012

Volltextzugriff (PDF)

From curing to caring: one character change makes a world of difference. Issues related to withholding/withdrawing renal replacement therapy (RRT) from patients with important co-morbidities

Nephrology, dialysis, transplantation, 2004-03, Vol.19 (3), p.536-540

2004

Volltextzugriff (PDF)

The Impact of the Pre-Transplant Renal Replacement Modality on Outcome After Cadaveric Kidney Transplantation: The Ghent Experience

Contributions to nephrology, 2006-01, Vol.150, p.254-258

2006

Volltextzugriff (PDF)

Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients

Thrombosis and haemostasis, 1997-04, Vol.77 (4), p.650

1997

Volltextzugriff (PDF)

INTERNAL MEDICINE, RENAL ANAEMIA, AND ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)

Acta clinica belgica (English ed. Online), 2007-12, Vol.62 (6), p.396-407

2007

Volltextzugriff (PDF)

Intermittent Hemodialysis for Renal Replacement Therapy in Intensive Care: New Evidence for Old Truths

Contributions to nephrology, 2007-01, Vol.156, p.304-308

2007

Volltextzugriff (PDF)

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

Haematologica (Roma), 2015-09, Vol.100 (9), p.1139

2015

Volltextzugriff (PDF)

Effect of Membrane Permeability on Survival of Hemodialysis Patients

Journal of the American Society of Nephrology, 2009-03, Vol.20 (3), p.645-654

2009

Volltextzugriff (PDF)

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study

Leukemia, 2021-03, Vol.35 (3), p.893-896

2021

Volltextzugriff (PDF)

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study

Blood, 2014-04, Vol.123 (14), p.2157-2160

2014

Volltextzugriff (PDF)

Recombinant hirudin: A specific thrombin inhibiting anticoagulant for hemodialysis

Kidney international, 1994-06, Vol.45 (6), p.1754-1759

1994

Volltextzugriff (PDF)

Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta

Clinical nephrology, 1998-01, Vol.49 (1), p.41

1998

Volltextzugriff (PDF)

The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes

Nephrology, dialysis, transplantation, 2006-01, Vol.21 (1), p.77-83

2006

Volltextzugriff (PDF)

Evaluation of the Peritoneal Membrane Function by Three Letter Word Acronyms: PET,PDC®, SPA, PD-Adequest, POL: What to Do?

Contributions to nephrology, 2006-01, Vol.150, p.37-41

2006

Volltextzugriff (PDF)

CHRONIC KIDNEY DISEASE: THE CINDERELLA OF GENERAL MEDICINE: Epidemiology of and screening for CKD in Belgium

Acta clinica belgica (English ed. Online), 2006-11, Vol.61 (6), p.319-325

2006

Volltextzugriff (PDF)

An evaluation of an integrative care approach for end-stage renal disease patients

Journal of the American Society of Nephrology, 2000, Vol.11 (1), p.116-125

2000

Volltextzugriff (PDF)

New concepts in peritoneal dialysis: new wine in old barrels?

Artificial organs, 2003-05, Vol.27 (5), p.398-405

2003

Volltextzugriff (PDF)

Why less success of the peritoneal dialysis programmes in Europe?

Nephrology, dialysis, transplantation, 2008-05, Vol.23 (5), p.1478-1481

2008

Volltextzugriff (PDF)

Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis

Leukemia, 2013-05, Vol.27 (5), p.1072-1079

2013

Volltextzugriff (PDF)

Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation

Transplantation, 2005-02, Vol.79 (3), p.367

2005

Volltextzugriff (PDF)

Exit-site infection--is there an alternative to catheter removal?

Nephrology, dialysis, transplantation, 1995-12, Vol.10 (12), p.2184-2186

1995

Volltextzugriff (PDF)

Alternative Timeframes for Hemodialysis

Artificial organs, 2002-02, Vol.26 (2), p.160-162

2002

Volltextzugriff (PDF)

1 – 25 von 285

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Dialysis water and fluid purity: more than endotoxin

From curing to caring: one character change makes a world of difference. Issues related to withholding/withdrawing renal replacement therapy (RRT) from patients with important co-morbidities

The Impact of the Pre-Transplant Renal Replacement Modality on Outcome After Cadaveric Kidney Transplantation: The Ghent Experience

Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients

INTERNAL MEDICINE, RENAL ANAEMIA, AND ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)

Intermittent Hemodialysis for Renal Replacement Therapy in Intensive Care: New Evidence for Old Truths

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

Effect of Membrane Permeability on Survival of Hemodialysis Patients

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study

Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study

Recombinant hirudin: A specific thrombin inhibiting anticoagulant for hemodialysis

Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta

The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes

Evaluation of the Peritoneal Membrane Function by Three Letter Word Acronyms: PET,PDC®, SPA, PD-Adequest, POL: What to Do?

CHRONIC KIDNEY DISEASE: THE CINDERELLA OF GENERAL MEDICINE: Epidemiology of and screening for CKD in Belgium

An evaluation of an integrative care approach for end-stage renal disease patients

New concepts in peritoneal dialysis: new wine in old barrels?

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Why less success of the peritoneal dialysis programmes in Europe?

Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis

Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

Exit-site infection--is there an alternative to catheter removal?

Alternative Timeframes for Hemodialysis

Suchergebnisse filtern